Diabetic Neuropathy, Painful Completed Phase 2 Trials for Pregabalin (DB00230)

IndicationStatusPhase
DBCOND0030279 (Diabetic Neuropathy, Painful)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00785577A Study for Treatment of Pain in Patients With Diabetic Neuropathy.Treatment
NCT02215252A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)Treatment